Home » Topics » Regulatory » Patents

Patents
RSS

Dana-Farber Cancer Institute discloses new HER2 inhibitors

April 29, 2022

Vertex Pharmaceuticals patents CFTR potentiators

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

Medy-Tox patents new BTK inhibitors

April 28, 2022

University of Texas System identifies CBP and/or p300 inhibitors

April 28, 2022

Humanwell Healthcare presents new P2X3 receptor antagonists

April 28, 2022

New YAP1/TEAD interaction inhibitors disclosed by SpringWorks Therapeutics and collaborators

April 28, 2022

Chinese researchers divulge new compounds for cancer

April 28, 2022

AstraZeneca presents new PROTACs for cancer

April 27, 2022

Cullgen identifies new PROTACs

April 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...